Shintaku H, Isshiki G, Hase Y, Tsuruhara T, Oura T
J Inherit Metab Dis. 1982;5(4):241-2. doi: 10.1007/BF02179155.
Tetrahydrobiopterin (BH4) deficiency has been described as a form of hyperphenylalaninaemia in which severe neurological symptoms develop despite early treatment with low phenylalanine diet. In recent years it has become apparent that biopterin deficiency may be caused by a defect either of dihydropteridine reductase (DHPR, EC 1.6.99.10) or dihydrobiopterin synthetase (DHBS) (Niederwieser et al., 1979). Since it was proposed that treatment with precursors of the neurotransmitters involved could prevent neurological deterioration if started within the first months after birth (Curtius et al., 1979), screening of all neonates with hyperphenylalaninaemia for biopterin disorders, and a non-invasive reliable method for the diagnosis of two types of BH4 deficiency are needed urgently. Assessment of pterin derivatives in biological fluids, mostly in urine, by high performance liquid chromatography (HPLC) is proposed as a reliable diagnostic method and Crithidia fasciculata bioassay is also a very sensitive method of measuring biopterin activity. Thus normal values of pterin derivatives during the neonatal period are needed. Nevertheless, few reports on a small number of neonates have so far been found (Niederwieser et al., 1980). In this study we describe normal values of pterin derivatives in urine and biopterin activity in serum, and their age-related change in early neonates, young infants, children and adults.
四氢生物蝶呤(BH4)缺乏症被描述为一种高苯丙氨酸血症,即使早期采用低苯丙氨酸饮食治疗,仍会出现严重的神经症状。近年来,越来越明显的是,生物蝶呤缺乏可能是由二氢蝶啶还原酶(DHPR,EC 1.6.99.10)或二氢生物蝶呤合成酶(DHBS)缺陷引起的(Niederwieser等人,1979年)。自从有人提出,如果在出生后的头几个月内开始用相关神经递质的前体进行治疗,可以预防神经功能恶化(Curtius等人,1979年)以来,迫切需要对所有高苯丙氨酸血症新生儿进行生物蝶呤紊乱筛查,以及一种用于诊断两种类型BH4缺乏症的非侵入性可靠方法。通过高效液相色谱法(HPLC)评估生物体液(主要是尿液)中的蝶呤衍生物,被认为是一种可靠的诊断方法,而克氏锥虫生物测定法也是一种测量生物蝶呤活性的非常敏感的方法。因此,需要新生儿期蝶呤衍生物的正常值。然而,到目前为止,仅发现了少数关于少量新生儿的报告(Niederwieser等人,1980年)。在本研究中,我们描述了尿液中蝶呤衍生物的正常值和血清中的生物蝶呤活性,以及它们在早期新生儿、幼儿、儿童和成人中的年龄相关变化。